|
GNPDA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.392800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.596600E-01 |
| Normal-vs-Stage2 |
4.226400E-01 |
| Normal-vs-Stage3 |
5.525000E-01 |
| Normal-vs-Stage4 |
3.643600E-01 |
| Stage1-vs-Stage2 |
4.256000E-01 |
| Stage1-vs-Stage3 |
5.188600E-01 |
| Stage1-vs-Stage4 |
2.951200E-01 |
| Stage2-vs-Stage3 |
2.517800E-01 |
| Stage2-vs-Stage4 |
7.048600E-01 |
| Stage3-vs-Stage4 |
1.981970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.332600E-01 |
| Normal-vs-AfricanAmerican |
4.820800E-01 |
| Normal-vs-Asian |
5.648000E-01 |
| Caucasian-vs-AfricanAmerican |
3.591600E-01 |
| Caucasian-vs-Asian |
6.811400E-01 |
| AfricanAmerican-vs-Asian |
4.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.611200E-01 |
| Normal-vs-Female |
4.756000E-01 |
| Male-vs-Female |
3.516200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.934400E-01 |
| Normal-vs-Extreme_Weight |
9.638600E-01 |
| Normal-vs-Obese |
6.610200E-01 |
| Normal-vs-Extreme_Obese |
9.426600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.305800E-01 |
| Normal_Weight-vs-Obese |
5.215200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.282200E-01 |
| Extreme_Weight-vs-Obese |
6.369800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.739200E-01 |
| Obese-vs-Extreme_Obese |
7.745800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.576000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.781560E-01 |
| Normal-vs-Age(61-80Yrs) |
3.990600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.239000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.355400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.608600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.395000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.046070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.745950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.917000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.290400E-01 |
| Normal-VS-Type2 PRCC |
1.355170E-01 |
| Normal-VS-KIRP CIMP |
7.545900E-02 |
| Normal-VS-Unclassified PRCC |
4.172400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.405650E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.645800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.579400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.712400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.456400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.954200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.381210E-01 |
| Normal-vs-N1 |
7.902800E-01 |
| Normal-vs-N2 |
9.478200E-01 |
| N0-vs-N1 |
3.496800E-01 |
| N0-vs-N2 |
4.991000E-01 |
| N1-vs-N2 |
8.464400E-01 |
|
|
